Droplette
Cambridge
About Droplette
Droplette is their patent-pending transdermal delivery system for delivery of drugs up to 60% larger than current treatments deep into skin over large surface areas. Their unique device is painless, contact free, portable and generates no disposables. It is designed to deliver antibiotics for serious ulcers and skin infections, reducing risk secondary complications or antibiotic resistance. Future applications include localized delivery of chemotherapeutics for skin cancer and drugs for anti-aging.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $21.0M
- Last round: Series Unknown (May 2024)
- Website: droplette.io
- Phone: [email protected]
Industries & Categories
Biotechnology, Cosmetics, Health Care, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/droplette-91986 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.